Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.
Ohwada
C
C
Nakaseko
C
C
Sakai
S
S
Takeda
Y
Y
Abe
D
D
Takeuchi
M
M
Sakaida
E
E
Masuda
S
S
Shimizu
N
N
Cho
R
R
Nishimura
M
M
Kanai
K
K
Misawa
S
S
Kuwabara
S
S
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D016878:POEMS Syndrome / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D013792:Thalidomide / Q000008:administration & dosage*; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D013792:Thalidomide